5 Most Promising Penny Stocks According to Analysts

4. Synlogic, Inc. (NASDAQ:SYBX)

Average Analyst Price Estimate: $5.50

Upside Potential: 1006.64%

Massachusetts-based biopharmaceutical company Synlogic, Inc. (NASDAQ:SYBX) is engaged in the development of synthetic biotics to treat metabolic and immunological diseases in the United States. In July Synlogic, Inc. (NASDAQ:SYBX) jumped after the company said the FDA issued Fast Track designation to the company’s experimental therapy labafenogene marselecobac to treat the rare metabolic disorder phenylketonuria.

As of the end of the first quarter of 2023, 7 hedge funds tracked by Insider Monkey were long Synlogic, Inc. (NASDAQ:SYBX). The biggest stakeholder of Synlogic, Inc. (NASDAQ:SYBX) during this period was Samuel Isaly’s OrbiMed Advisors which owns a $3.8 million stake in the company.